SARS-CoV-2 vaccination efficacy on hospitalisation and variants - 09/06/21
Doi : 10.1016/j.accpm.2021.100874
Sacha Rozencwajg a, b, ⁎ 
, Alice Blet c, d, e, Antoine Lamer f, Thomas Clavier g, h, Osama Abou-Arab i, Stéphanie Sigaut j, k, Fanny Bounes l, m, Arthur James n, Denis Frasca o, p, Matthieu Boisson o, q, Anaïs Caillard r, Aude Carillion n, h, Marc-Olivier Fischer s
, Alice Blet c, d, e, Antoine Lamer f, Thomas Clavier g, h, Osama Abou-Arab i, Stéphanie Sigaut j, k, Fanny Bounes l, m, Arthur James n, Denis Frasca o, p, Matthieu Boisson o, q, Anaïs Caillard r, Aude Carillion n, h, Marc-Olivier Fischer s a AP-HP, Bichat University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Paris, France
b INSERM UMRS-1166, Institute of Cardiometabolism and Nutrition, Paris, France
c Lariboisière–Saint-Louis Hospitals, Department of Anaesthesiology, Critical Care and Burn Centre, DMU Parabol, AP–HP Nord, University of Paris, Paris, France
d University of Paris, Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Paris, France
e University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada
f Univ. Lille, CHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de santé et des Pratiques médicales, F-59000, Lille, France
g Department of Anaesthesiology, Critical Care and Perioperative Medicine, Rouen University Hospital, 1 rue de Germont, 76000 Rouen, France
h Normandie Univ, UNIROUEN, Inserm U1096, EnVi, Rouen F-76000, France
i University of Amiens-Picardie, Departement of Anaesthesia and Critical Care, Amiens, France
j AP-HP, Beaujon University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Clichy, France
k Inserm U1141 NeuroDiderot, Robert Debré Hospital, Paris, France
l University Hospital of Toulouse, Anaesthesia, Critical Care & Perioperative Medicine, Toulouse, France
m University of Toulouse III, INSERM U1297, Institute of Cardiovascular and Metabolic Diseases, Toulouse, France
n Sorbonne University, GRC 29, AP-HP, DMU DREAM, Department of Anaesthesiology and critical care, Pitié-Salpêtrière Hospital, Paris, France
o University Hospital of Poitiers, Anaesthesiology, Critical Care and Perioperative Medicine Department, Poitiers, France
p INSERM UMR-1246, France
q INSERM U1070, Pharmacology of Antimicrobial Agents, University of Poitiers, France
r Centre Hospitalier Universitaire La Cavale Blanche Université de Bretagne Ouest, Departement of Anaesthesiology, Critical Care and Perioperative Medicine, Brest, France
s Normandie Univ, UNICAEN, CHU de Caen Normandie, Service d’Anesthésie Réanimation, 14000 Caen, France
⁎Corresponding author. AP-HP, Bichat University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Paris, FranceAP-HP, Bichat University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical CareParisFrance
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Resumen |
We report data regarding three countries with similar healthcare systems which had three different vaccinal strategies between 1st of January and 10th of April 2021: rapid full vaccination (Israel), rapid first-dose vaccination (United Kingdom) and a delayed vaccination strategy (France).
El texto completo de este artículo está disponible en PDF.Esquema
© 2021
Publicado por Elsevier Masson SAS.
Vol 40 - N° 3
Artículo 100874- juin 2021 Regresar al número
Artículo precedente
- Contents
- ICU bed capacity during COVID-19 pandemic in France: From ephemeral beds to continuous and permanent adaptation
- Jean-Yves Lefrant, Romain Pirracchio, Dan Benhamou, Bertrand Dureuil, Julien Pottecher, Emmanuel Samain, Olivier Joannes-Boyau, Hervé Bouaziz
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.